| 30th May 2025 7:00 am |
RNS |
Holding(s) in Company |
| 28th May 2025 7:00 am |
RNS-R |
Conference attendance at Mello2025 Investor event |
| 16th May 2025 7:00 am |
RNS |
Exercise of Share Options and Total Voting Rights |
| 15th May 2025 7:00 am |
RNS |
CFO succession planning |
| 12th May 2025 7:00 am |
RNS |
FDA clearance for Tristel OPH |
| 10th Apr 2025 7:00 am |
RNS |
Additional info. submitted to FDA for Tristel OPH |
| 9th Apr 2025 7:00 am |
RNS |
Publication of Poster by Mayo Clinic & US update |
| 2nd Apr 2025 7:00 am |
RNS |
Director/PDMR Shareholding |
| 31st Mar 2025 8:56 am |
RNS |
Holding(s) in Company |
| 26th Mar 2025 10:30 am |
RNS |
Director/PDMR Shareholding |
| 18th Mar 2025 2:39 pm |
RNS |
Holding(s) in Company |
| 24th Feb 2025 7:00 am |
RNS |
Unaudited Interim Results |
| 7th Feb 2025 7:00 am |
RNS |
Exercise of Share Options and Total Voting Rights |
| 23rd Jan 2025 7:00 am |
RNS |
Director Option Grant |
| 13th Jan 2025 7:00 am |
RNS |
Confirmation of Interim Results |
| 16th Dec 2024 2:45 pm |
RNS |
Result of AGM |
| 16th Dec 2024 7:00 am |
RNS |
AGM Statement and Notice of Interim Results |
| 22nd Nov 2024 10:30 am |
RNS |
Notice of AGM & Posting of Annual Report &Accounts |
| 21st Nov 2024 1:32 pm |
RNS |
Exercise of Share Options and Total Voting Rights |
| 20th Nov 2024 8:47 am |
RNS |
Exercise of Share Options and Total Voting Rights |
| 28th Oct 2024 1:37 pm |
RNS |
Exercise of Share Options and Total Voting Rights |
| 21st Oct 2024 7:00 am |
RNS |
Final Results |
| 1st Oct 2024 7:00 am |
RNS |
Notice of Preliminary Results |
| 20th Sep 2024 7:00 am |
RNS |
Director/PDMR Shareholding |
| 19th Sep 2024 1:13 pm |
RNS |
Exercise of Share Options and Total Voting Rights |
| 12th Sep 2024 7:00 am |
RNS |
FDA 510(k) submission for Tristel OPH |
| 2nd Sep 2024 7:00 am |
RNS |
Confirmation of CEO Transition, Directorate Change |
| 6th Aug 2024 3:32 pm |
RNS |
Exercise of Share Options and Total Voting Rights |
| 22nd Jul 2024 7:00 am |
RNS |
Trading Update |
| 4th Jul 2024 3:43 pm |
RNS |
Exercise of Share Options and Total Voting Rights |
| 11th Jun 2024 5:48 pm |
RNS |
Director/PDMR Shareholding |
| 11th Jun 2024 3:50 pm |
RNS |
Holding(s) in Company |
| 10th Jun 2024 7:00 am |
RNS |
Appointment of CEO |
| 8th May 2024 7:00 am |
RNS |
Tristel™ ULT case study |
| 7th May 2024 7:00 am |
RNS |
Exercise of Share Options and Total Voting Rights |
| 16th Apr 2024 2:04 pm |
RNS |
Director/PDMR Shareholding |
| 15th Apr 2024 5:56 pm |
RNS |
Exercise of Share Options and Total Voting Rights |
| 19th Mar 2024 9:25 am |
RNS |
Exercise of Share Options and Total Voting Rights |
| 27th Feb 2024 7:00 am |
RNS |
Exercise of Share Options and Total Voting Rights |
| 26th Feb 2024 7:01 am |
RNS |
Half-year Report |
